Stanley Druckenmiller’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Stanley Druckenmiller’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-399,748	Closed	-$8.52M	–	92
2024 Q1	$8.52M	Buy	+399,748	New	+$4.78M	0.19%	49

Stanley Druckenmiller's FUSN Position: Q2 2024 in Review

Stanley Druckenmiller sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 399,748 shares — an estimated $8.52M sold.

Stanley Druckenmiller first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $8.52M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Stanley Druckenmiller reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Stanley Druckenmiller sold 399,748 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $8.52M.
Stanley Druckenmiller first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Stanley Druckenmiller's Fusion Pharmaceuticals Inc. Common Shares position peaked at $8.52M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Duquesne Family Office's 13F filing for Q2 2024, filed 14 Aug 2024.